menopause and tirzepatide Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 The role of menopause hormone

Key points include salt forms, delivery and dosing differences, known risks and contraindications, and how telehealth evaluation and follow up verify product quality, manage side effects, and track results

By integrating both API and formulation development in-house, we are able to maintain greater control across the entire value chain from development through to commercialization, while ensuring a reliable and consistent supply of this important therapy for patients in Canada

Understanding when its time to make that shift can empower you to take control of your health and set the stage for long-term success

A 503A-listed substance can be legally compounded by pharmacies for individual patients with a prescription, but it does not carry FDA drug approval status

The recall was initiated following a report of an allergic reaction from one consumer

Glucagon-like peptide-1 agonists for treating obesity in patients with immune-mediated skin diseases